{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:40:39Z","timestamp":1788864039513,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-025-11823-7","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T18:57:57Z","timestamp":1752951477000},"page":"731-742","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thermal ablation for radioactive iodine refractory cervical lymph node metastasis in differentiated thyroid cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Jianping","family":"Dou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songyuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7640-2351","authenticated-orcid":false,"given":"Ping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"11823_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"11823_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41574-020-00448-z","volume":"17","author":"M Schlumberger","year":"2021","unstructured":"Schlumberger M, Leboulleux S (2021) Current practice in patients with differentiated thyroid cancer. Nat Rev Endocrinol 17:176\u2013188","journal-title":"Nat Rev Endocrinol"},{"key":"11823_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid cancer: a review. JAMA 331:425\u2013435","journal-title":"JAMA"},{"key":"11823_CR4","doi-asserted-by":"publisher","first-page":"738213","DOI":"10.3389\/fendo.2021.738213","volume":"12","author":"F Cheng","year":"2021","unstructured":"Cheng F, Xiao J, Shao C et al (2021) Burden of thyroid cancer From 1990 to 2019 and projections of incidence and mortality until 2039 in China: findings from global burden of disease study. Front Endocrinol 12:738213","journal-title":"Front Endocrinol"},{"key":"11823_CR5","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.3390\/cancers11091382","volume":"11","author":"M Aashiq","year":"2019","unstructured":"Aashiq M, Silverman DA, Na\u2019ara S, Takahashi H, Amit M (2019) Radioiodine-refractory thyroid cancer: molecular basis of redifferentiation therapies, management, and novel therapies. Cancers (Basel) 11:1382","journal-title":"Cancers (Basel)"},{"key":"11823_CR6","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.eprac.2022.03.373","volume":"28","author":"AK Arida","year":"2022","unstructured":"Arida AK, Papaleontiou M (2022) To radiate or not to radiate? Adjuvant external beam radiation therapy for nonanaplastic thyroid cancer. Endocr Pract 28:732\u2013733","journal-title":"Endocr Pract"},{"key":"11823_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","volume":"384","author":"MS Brose","year":"2014","unstructured":"Brose MS, Nutting CM, Jarzab B et al (2014) Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial. Lancet 384:319\u2013328","journal-title":"Lancet"},{"key":"11823_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMoa1406470","volume":"372","author":"M Schlumberger","year":"2015","unstructured":"Schlumberger M, Tahara M, Wirth LJ et al (2015) Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med 372:621\u2013630","journal-title":"N Engl J Med"},{"key":"11823_CR9","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1158\/1078-0432.CCR-22-3613","volume":"29","author":"Y Lin","year":"2023","unstructured":"Lin Y, Qin S, Yang H et al (2023) Multicenter randomized double-blind phase III trial of donafenib in progressive radioactive iodine-refractory differentiated thyroid cancer. Clin Cancer Res 29:2791\u20132799","journal-title":"Clin Cancer Res"},{"key":"11823_CR10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1001\/jamaoncol.2021.6268","volume":"8","author":"Y Lin","year":"2022","unstructured":"Lin Y, Qin S, Li Z et al (2022) Apatinib vs placebo in patients with locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: the REALITY randomized clinical trial. JAMA Oncol 8:242\u2013250","journal-title":"JAMA Oncol"},{"key":"11823_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1\u2013133","journal-title":"Thyroid"},{"key":"11823_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3348\/kjr.2018.19.4.632","volume":"19","author":"JH Kim","year":"2018","unstructured":"Kim JH, Baek JH, Lim HK et al (2018) 2017 Thyroid Radiofrequency Ablation Guideline: Korean Society of Thyroid Radiology. Korean J Radiol 19:632\u2013655","journal-title":"Korean J Radiol"},{"key":"11823_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1159\/000508484","volume":"9","author":"E Papini","year":"2020","unstructured":"Papini E, Monpeyssen H, Frasoldati A, Heged\u00fcs L (2020) 2020 European Thyroid Association Clinical Practice Guideline for the use of image-guided ablation in benign thyroid nodules. Eur Thyroid J 9:172\u2013185","journal-title":"Eur Thyroid J"},{"key":"11823_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1007\/s12020-023-03660-9","volume":"85","author":"Z Yang","year":"2024","unstructured":"Yang Z, Zhang M, Yan L et al (2024) Value of radiofrequency ablation for treating locally recurrent thyroid cancer: a systematic review and meta-analysis for 2-year follow-up. Endocrine 85:1066\u20131074","journal-title":"Endocrine"},{"key":"11823_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.738299","volume":"12","author":"Z Ding","year":"2022","unstructured":"Ding Z, Chen J, Chen Z et al (2022) Efficacy and safety of thermal ablation for treating lymph node metastasis from papillary thyroid carcinoma: a systematic review and meta-analysis. Front Oncol 12:738299","journal-title":"Front Oncol"},{"key":"11823_CR16","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad066","volume":"7","author":"S Ahmad","year":"2023","unstructured":"Ahmad S, Aljammal J, Orozco I et al (2023) Radiofrequency ablation of cervical thyroid cancer metastases-experience of endocrinology practices in the United States. J Endocr Soc 7:bvad066","journal-title":"J Endocr Soc"},{"key":"11823_CR17","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.3390\/jcm10225295","volume":"10","author":"C Offi","year":"2021","unstructured":"Offi C, Misso C, Antonelli G, Esposito MG, Brancaccio U, Spiezia S (2021) Laser ablation treatment of recurrent lymph node metastases from papillary thyroid carcinoma. J Clin Med 10:5295","journal-title":"J Clin Med"},{"key":"11823_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.967044","volume":"13","author":"W Tang","year":"2022","unstructured":"Tang W, Tang X, Jiang D et al (2022) Safety and efficacy of thermal ablation for cervical metastatic lymph nodes in papillary thyroid carcinoma: A systematic review and meta-analysis. Front Endocrinol 13: 967044","journal-title":"Front Endocrinol"},{"key":"11823_CR19","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s11912-024-01616-4","volume":"26","author":"DD Chlorogiannis","year":"2024","unstructured":"Chlorogiannis DD, Charalampopoulos G, Kontopyrgou D et al (2024) Emerging indications for interventional oncology: a comprehensive systematic review of image-guided thermal ablation for metastatic non-cervical lymph node disease. Curr Oncol Rep 26:1543\u20131552","journal-title":"Curr Oncol Rep"},{"key":"11823_CR20","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.acra.2024.12.064","volume":"32","author":"A Upadhyaya","year":"2025","unstructured":"Upadhyaya A, Upadhyaya SA, Chang L, Yuanyuan L, Xi W (2025) Ultrasound\u2011guided percutaneous radiofrequency and microwave ablation for cervical lymph node metastasis from papillary thyroid carcinoma: a systematic review and meta\u2011analysis of clinical efficacy and safety. Acad Radiol 32:2533\u20132544","journal-title":"Acad Radiol"},{"key":"11823_CR21","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.21037\/gs-24-285","volume":"13","author":"A LaForteza","year":"2024","unstructured":"LaForteza A, Persons E, Hussein M et al (2024) Treatment outcomes in patients with papillary thyroid cancer undergoing radiofrequency ablation of metastatic lymph nodes. Gland Surg 13:1752\u20131758","journal-title":"Gland Surg"},{"key":"11823_CR22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1080\/02656736.2020.1805128","volume":"37","author":"ZY Han","year":"2020","unstructured":"Han ZY, Dou JP, Cheng ZG et al (2020) Efficacy and safety of percutaneous ultrasound-guided microwave ablation for cervical metastatic lymph nodes from papillary thyroid carcinoma. Int J Hyperthermia 37:971\u2013975","journal-title":"Int J Hyperthermia"},{"key":"11823_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/thy.2018.0604","volume":"29","author":"G Mauri","year":"2019","unstructured":"Mauri G, Pacella CM, Papini E et al (2019) Image-guided thyroid ablation: proposal for standardization of terminology and reporting criteria. Thyroid 29:611\u2013618","journal-title":"Thyroid"},{"key":"11823_CR24","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.3390\/diagnostics12123154","volume":"12","author":"M Dotinga","year":"2022","unstructured":"Dotinga M, Vriens D, van Velden FHP et al (2022) Reinducing radioiodine-sensitivity in radioiodine-refractory thyroid cancer using lenvatinib (RESET): study protocol for a single-center, open label phase II trial. Diagnostics (Basel) 12:3154","journal-title":"Diagnostics (Basel)"},{"key":"11823_CR25","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1158\/1078-0432.CCR-23-0046","volume":"29","author":"S Leboulleux","year":"2023","unstructured":"Leboulleux S, Do Cao C, Zerdoud S et al (2023) A phase II redifferentiation trial with dabrafenib-trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-mutated differentiated thyroid cancer. Clin Cancer Res 29:2401\u20132409","journal-title":"Clin Cancer Res"},{"key":"11823_CR26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1089\/thy.2011.0232","volume":"21","author":"F Vaisman","year":"2011","unstructured":"Vaisman F, Tala H, Grewal R, Tuttle RM (2011) In differentiated thyroid cancer, an incomplete structural response to therapy is associated with significantly worse clinical outcomes than only an incomplete thyroglobulin response. Thyroid 21:1317\u20131322","journal-title":"Thyroid"},{"key":"11823_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ajco.13836","volume":"19","author":"Q Yu","year":"2023","unstructured":"Yu Q, Zhang X, Li L, Zhang C, Huang J, Huang W (2023) Molecular basis and targeted therapies for radioiodine refractory thyroid cancer. Asia Pac J Clin Oncol 19:279\u2013289","journal-title":"Asia Pac J Clin Oncol"},{"key":"11823_CR28","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1515\/cclm-2022-0154","volume":"60","author":"L Giovanella","year":"2022","unstructured":"Giovanella L, Ceriani L, Garo ML (2022) Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis. Clin Chem Lab Med 60:1091\u20131100","journal-title":"Clin Chem Lab Med"},{"key":"11823_CR29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11604-023-01517-9","volume":"42","author":"K Watanabe","year":"2024","unstructured":"Watanabe K, Igarashi T, Uchiyama M, Ishigaki T, Ojiri H (2024) Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer. Jpn J Radiol 42:391\u2013397","journal-title":"Jpn J Radiol"},{"key":"11823_CR30","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.3390\/cancers15112976","volume":"15","author":"A Signore","year":"2023","unstructured":"Signore A, Lauri C, Di Paolo A et al (2023) Predictive role of serum thyroglobulin after surgery and before radioactive iodine therapy in patients with thyroid carcinoma. Cancers (Basel) 15:2976","journal-title":"Cancers (Basel)"},{"key":"11823_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1515\/cclm-2019-0654","volume":"58","author":"L Giovanella","year":"2019","unstructured":"Giovanella L, Castellana M, Trimboli P (2019) Unstimulated high-sensitive thyroglobulin is a powerful prognostic predictor in patients with thyroid cancer. Clin Chem Lab Med 58:130\u2013137","journal-title":"Clin Chem Lab Med"},{"key":"11823_CR32","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2022-0506","volume":"68","author":"A Ywata de Carvalho","year":"2024","unstructured":"Ywata de Carvalho A, Kohler HF, Ywata de Carvalho CCG, Vartanian JG, Kowalski LP (2024) Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment. Arch Endocrinol Metab 68:e220506","journal-title":"Arch Endocrinol Metab"},{"key":"11823_CR33","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.surg.2011.02.004","volume":"151","author":"YK So","year":"2012","unstructured":"So YK, Seo MY, Son YI (2012) Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications. Surgery 151:192\u2013198","journal-title":"Surgery"},{"key":"11823_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1148\/radiol.2021202735","volume":"300","author":"XJ Cao","year":"2021","unstructured":"Cao XJ, Wang SR, Che Y et al (2021) Efficacy and safety of thermal ablation for treatment of solitary T1N0M0 papillary thyroid carcinoma: a multicenter retrospective study. Radiology 300:209\u2013216","journal-title":"Radiology"},{"key":"11823_CR35","doi-asserted-by":"publisher","first-page":"7942","DOI":"10.1007\/s00330-023-09802-x","volume":"33","author":"ZY Han","year":"2023","unstructured":"Han ZY, Dou JP, Zheng L et al (2023) Safety and efficacy of microwave ablation for the treatment of low-risk papillary thyroid microcarcinoma: a prospective multicenter study. Eur Radiol 33:7942\u20137951","journal-title":"Eur Radiol"},{"key":"11823_CR36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1148\/radiol.212313","volume":"304","author":"Y Wei","year":"2022","unstructured":"Wei Y, Niu WQ, Zhao ZL et al (2022) Microwave ablation versus surgical resection for solitary T1N0M0 papillary thyroid carcinoma. Radiology 304:704\u2013713","journal-title":"Radiology"},{"key":"11823_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.952113","volume":"13","author":"MH Wang","year":"2022","unstructured":"Wang MH, Liu X, Wang Q, Zhang HW (2022) Safety and efficacy of ultrasound-guided thermal ablation in treating T1aN0M0 and T1bN0M0 papillary thyroid carcinoma: a meta-analysis. Front Endocrinol 13:952113","journal-title":"Front Endocrinol"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-11823-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-11823-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T14:01:00Z","timestamp":1765980060000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-11823-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["11823"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-11823-7","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"12 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Ping Liang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Study subjects or cohorts have not been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}